Mystic Asset Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
DAM
F
Mystic Asset Management's NVO Position: Q1 2026 in Review
Mystic Asset Management reduced its Novo Nordisk (NVO) stake by 2.9% in Q1 2026, selling an estimated $17.8K and leaving 12,425 shares worth $457K. The position accounts for 0.11% of the portfolio, ranked #150.
Mystic Asset Management first reported a position in NVO in Q4 2021 and has held it in 18 quarters since. The position peaked at $2.02M in Q2 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.
- Mystic Asset Management held 12,425 shares of Novo Nordisk worth $457K as of Q1 2026.
- Mystic Asset Management sold 375 Novo Nordisk shares in Q1 2026, an estimated $17.8K.
- Novo Nordisk made up 0.11% of Mystic Asset Management's portfolio in Q1 2026, its #150 holding.
- Mystic Asset Management first reported a position in Novo Nordisk in Q4 2021 and has held it in 18 quarters since.
- Mystic Asset Management's Novo Nordisk position peaked at $2.02M in Q2 2024.
- 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.
Based on Mystic Asset Management's 13F filing for Q1 2026, filed 8 May 2026.